macular degeneration leading cause blindness developing countries irradiating exudative form choroidal neovascular membrane develops subfoveal area presently treatment investigation NUMBER massachusetts general hospital collaborating massachusetts eye ear infirmary initiated protocol treat scnv membranes using proton beam harvard cyclotron laboratory eyeplan program setup eyeplan requires axial eye length membrane dimensions manipulation eye include radial margin membrane aperture margin NUMBER isodose line posterior retina abuts inferior aspect limbus review NUMBER individually prepared plans showed NUMBER fabricated apertures circular aspect ratio NUMBER diameters NUMBER NUMBER mm information used develop automated standard plan plans developed axial lengths ranging NUMBER NUMBER mm membrane sizes NUMBER NUMBER mm usual way reviewed ones circular targets outlined centered fovea distal proximal NUMBER ranges modulation target doses macula optic disc lens ciliary body retina globe calculated automated standard plan requiring input data avoiding need individual plans developed program outputs aperture diameter fixation angle setup range modulation calculates dose macula optic nerve percentage retina receiving NUMBER NUMBER prescribed dose individual plans require approximately NUMBER hours standard plan NUMBER minutes standard plan treated NUMBER reviewed plans automated plan provides accurate efficient treatment parameters majority patients age related light field NUMBER mm thirty light field